Cantor Fitzgerald Weighs in on Ardelyx FY2026 Earnings
Ardelyx, Inc. (NASDAQ:ARDX – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of Ardelyx in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst P. Agrawal forecasts that the biopharmaceutical company will post earnings of ($0.05) per share for […]
Ardelyx, Inc. (NASDAQ:ARDX – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of Ardelyx in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst P. Agrawal forecasts that the biopharmaceutical company will post earnings of ($0.05) per share for […]
